The FDA’s Office of International Programs (OIP) is exploring development of a single, global recall system that would encompass all domestic and international recalls. The move toward a global system, currently in its early stages, would help address fast-growing gaps in global oversight of international product recalls, Mark Roh, regional food and drug director for the FDA’s Pacific Region, said.
Drug GMP Report